Profound Medical Corp (PROF)

Currency in USD
5.82
+0.02(+0.34%)
Real-time Data·
PROF Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 15 days
Fair Value
Day's Range
5.705.90
52 wk Range
3.9011.42
Key Statistics
Prev. Close
5.87
Open
5.77
Day's Range
5.7-5.9
52 wk Range
3.9-11.42
Volume
13.75K
Average Volume (3m)
58.34K
1-Year Change
-42.42%
Book Value / Share
1.69
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PROF Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to drop this year

Profound Medical Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Profound Medical Corp Company Profile

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. The company’s lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It also provides Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.

Profound Medical Corp Earnings Call Summary for Q4/2024

  • Profound Medical reported Q4 2024 EPS of $0.20, beating -$0.35 forecast; revenue up 108% YoY to $4.2M, slightly above expectations
  • Gross margin improved to 71% from 52% YoY; net loss reduced by 45% to $4.9M; cash position at $54.9M as of December 31, 2024
  • Company projects high double-digit growth in 2025, triple-digit revenue growth by 2026; plans BPH Tulsa AI module launch and Healthap Plus introduction
  • Stock declined 0.55% in after-hours trading despite earnings beat; analysts set price targets between $12 and $18
  • Focus on expanding private insurance coverage and overcoming reimbursement challenges to drive future growth
Last Updated: 06/03/2025, 23:32
Read Full Transcript

Compare PROF to Peers and Sector

Metrics to compare
PROF
Peers
Sector
Relationship
P/E Ratio
−5.6x−4.2x−0.5x
PEG Ratio
−1.31−0.320.00
Price/Book
3.5x4.9x2.6x
Price / LTM Sales
15.0x4.2x3.2x
Upside (Analyst Target)
91.7%45.8%42.7%
Fair Value Upside
Unlock−3.7%5.8%Unlock

Earnings

Latest Release
May 08, 2025
EPS / Forecast
0.36 / -0.29
Revenue / Forecast
2.62M / 3.37M
EPS Revisions
Last 90 days

PROF Income Statement

FAQ

What Stock Exchange Does Profound Medical Corp Trade On?

Profound Medical Corp is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Profound Medical Corp?

The stock symbol for Profound Medical Corp is "PROF."

What Is the Profound Medical Corp Market Cap?

As of today, Profound Medical Corp market cap is 174.91M.

What Is Profound Medical Corp's Earnings Per Share (TTM)?

The Profound Medical Corp EPS (TTM) is -1.22.

When Is the Next Profound Medical Corp Earnings Date?

Profound Medical Corp will release its next earnings report on 06 Aug 2025.

From a Technical Analysis Perspective, Is PROF a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Profound Medical Corp Stock Split?

Profound Medical Corp has split 1 times.

How Many Employees Does Profound Medical Corp Have?

Profound Medical Corp has 142 employees.

What is the current trading status of Profound Medical Corp (PROF)?

As of 23 Jul 2025, Profound Medical Corp (PROF) is trading at a price of 5.82, with a previous close of 5.87. The stock has fluctuated within a day range of 5.70 to 5.90, while its 52-week range spans from 3.90 to 11.42.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.